Nolato Ab Class B · OMXSTO:NOLA_B
Nolato Ab Class B — Q4 2023 Earnings Presentation
17 slides from Nolato Ab Class B's earnings presentation, Feb 6, 2024
Slide 1: Fourth quarter
Medical Solutions Fourth quarter Integrated Solutions CEO Christer Wahlquist CFO Per-Ola Holmström Industrial Solutions February 6, 2024
Slide 2: Q4 summary
Q4 summary Group A global solutions provider established on three continents ● Sales totaled SEK 2,252 million (2,364) - 6% decrease, adjusted for currency and acquisitions SEKm - Strong growth for Industrial Solutions, but lower 12000 volumes adversely affected other business areas 11000 ● Operatin
Slide 3: Full year 2023 in brief
Full year 2023 in brief Positioning as a global supplier of sustainable end-to-end solutions ● Sales totaled SEK 9,546 million (10,774) SEKm ● EBITA margin of 8.0% (8.4), excluding non- 12000 recurring items 11000 10000 ● Earnings per share were SEK 2.02 (2.44), 9000 excl. non-recurring items 8000 -
Slide 4: One Group – three business areas
One Group – three business areas Nolato Medical Solutions Integrated Solutions Industrial Solutions Our offering as a strategic partner for selected Development and manufacture of Design, development and Development and manufacture of global customers comprises development and complex product system
Slide 5: Medical Solutions – Sustainable Growth and Global expansion
Medical Solutions – Sustainable Growth and Global expansion SEKm 5500 5000 4500 4000 3500 3000 129 EBITA 2500 2000 1,300 SEKm, Q4 1500 1000 9.9 SALES SEKm, Q4 500 EBITA MARGIN 0 %, Q4 04 05 06 07 08 09 10 11 12 13 14 15 16 17 18 19 20 21 22 23 5
Slide 6: Medical Solutions – Focused product areas
Medical Solutions – Focused product areas Pharma Diagnostics Medical Devices Drug Delivery ~15% In Vitro Diagnostics (IVD) ~13% Endoscopy & General Surgery ~21% Cardiology ~8% Continence care ~12% Pharma Packaging ~13% Other ~18% 6
Slide 7: Medical Solutions – Q4
Medical Solutions – Q4 ● 1% decrease in sales Q4 Full year - 2% decrease, adjusted for currency SEKm 2023 2022 2023 2022 - Lower surgery volumes - IVD volumes were in line with the previous year Sales 1,300 1,312 5,308 4,859 - Solid demand in other product areas, but some impact from inventory adjus
Slide 8: Integrated Solutions – Expansion into new market segments
Integrated Solutions – Expansion into new market segments SEKm 5500 5000 4500 4000 3500 -1 EBITA 3000 2500 243 SEKm, Q4 2000 1500 -0.4 SALES 1000 SEKm, Q4 500 EBITA MARGIN %, Q4 0 04 05 06 07 08 09 10 11 12 13 14 15 16 17 18 19 20 21 22 23 8
Slide 9: Integrated Solutions – Focused product areas
Integrated Solutions – Focused product areas Consumer Electronics EMC & Thermal Trishield - Dispensing Gaskets Complex Modules Speakers Compashield - Extrusion & Molded Gaskets VHP MIL SPEC EMI Shielding In/On/Over Ear Headphones - Aerospace & Defence Wearable & Handheld Wellbeing Devices Thermal In
Slide 10: Integrated Solutions – Q4
Integrated Solutions – Q4 ● 40% decrease in sales Q4 Full year - A decrease of some 41%, adjusted for currency and acquisitions - Low volumes and a change in sourcing strategy at a previously significant customer SEKm 2023 2022 2023 2022 had a negative impact, as well as lower demand in consumer ele
Slide 11: Industrial Solutions – Technological and geographical expansion
Industrial Solutions – Technological and geographical expansion SEKm 3000 2800 2600 2400 2200 2000 1800 53 1600 1400 716 EBITA 1200 SEKm, Q4 1000 800 SALES SEKm, Q4 7.4 EBITA MARGIN 600 400 200 %, Q4 0 04 05 06 07 08 09 10 11 12 13 14 15 16 17 18 19 20 21 22 23 11
Slide 12: Industrial Solutions – Focused product areas
Industrial Solutions – Focused product areas Domestic appliances Packaging Hygiene Gardening/forestry Furniture sectors Automotive Other selected industrial segments 12
Slide 13: Industrial Solutions – Q4
Industrial Solutions – Q4 ● 10% increase in sales Q4 Full year - 7% increase, adjusted for currency SEKm 2023 2022 2023 2022 - Strong demand in automotive, as well as increased volumes in hygiene - Demand for products in consumer discretionary sector slightly lower due to weak economy Sales 716 651
Slide 14: Group financial highlights
Group financial highlights Q4 Full year SEKm 2023 2022 2023 2022 Net sales 2,252 2,364 9,546 10,774 Operating profit (EBITA)*) 177 163 701 908 Operating profit (EBITA), excl. non-recurring items in 2023 177 163 761 908 EBITA margin (%), excl. non-recurring items in 2023 7.9 6.9 8.0 8.4 Profit after
Slide 15: Change in Group structure
Change in Group structure • We have decided to merge Integrated Solutions and Medical Solutions Engineered Solutions Industrial Solutions to create a new Engineered Solutions business area • The merger provides a global offering for major new customers and our existing customer base • Global Technic
Slide 16: Current situation
Current situation Medical Solutions Engineered Solutions • Maintained growth strategy • Advanced market positions • Focus on margin – cost adjustments, pricing • Established position in new product areas strategy and efficiency • Focus on innovative and sustainable solutions • Innovation and sustain
Slide 17: Thank you.
Thank you. This presentation may contain forward-looking statements. When used in this presentation, words such as “anticipate”, “believe”, “estimate”, “expect”, “plan” and “project” are intended to identify forward-looking statements. Such statements could encompass risks and uncertainties pertaini